Category : Search result: Cliniexperts

Cliniexperts Completes Akynzeo Phase IV Study for Glenmark

Cliniexperts successfully concludes Phase IV study of Glenmark's Akynzeo for CINV prevention. Breakthrough in cancer care with proven efficacy and safety results.